Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Torii

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.

Gilead, Galapagos dip on mixed ulcerative colitis data

Gilead, Galapagos dip on mixed ulcerative colitis data

Filgotinib is already under regulatory review in the US, Europe and Japan as a treatment for rheumatoid arthritis, but Gilead and Galapagos will need to extend the use of the drug

Biopharma body welcomes EU-UK free trade agreement docs

Biopharma body welcomes EU-UK free trade agreement docs The UK seeks an FTA close to those agreed by the EU with Canada or Japan. ... union, and instead is seeking a free trade agreement (FTA) that “approximates very closely those the EU has agreed with Canada or Japan”.

FDA clears phase 2 COVID-19 trial of ViralClear’s merimepodib

FDA clears phase 2 COVID-19 trial of ViralClear’s merimepodib Aside from an emergency use authorisation for remdesivir and hydroxychloroquine/chloroquine in the US and a similar approval for remdesivir in Japan, there are no approved therapeutics options for the treatment

Novartis claims EU approval for SMA gene therapy Zolgensma

Novartis claims EU approval for SMA gene therapy Zolgensma Japan in March where it has been given a lower price of around $1.55m dollars.

Gilead signs generic drugmaker deals to boost remdesivir supply

Gilead signs generic drugmaker deals to boost remdesivir supply Companies not on the list include Brazil, China, Mexico and Russia, as well as the US and Japan which have already authorised the drug for use.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics